Shanghai Angel Cell Technology Co., Ltd. (abbreviated as: Angel Cell, stock code: 833926) was founded in 2010 by a team of experts returning from overseas studies in the United States. It is a high-tech enterprise engaged in cell drug development, cell therapy, cell testing, and cell storage, committed to providing comprehensive cell therapy solutions for patients suffering from stubborn diseases related to the central nervous system (such as Parkinson's disease, stroke, and cerebral palsy in children), the immune system, and tumors. The company possesses a standardized GMP cell production workshop, a cell R&D center, a cell testing center, and the Shanghai Tissue Engineering and Cell Bank. With the strong scientific support of domestic and international expert teams, the company has successfully achieved cutting-edge cell technologies including cell isolation and purification, culture expansion, cryopreservation and recovery, directed induction, and inspection and testing, which have now reached leading levels both at home and abroad. Since its establishment, the company's R&D and industrialization projects have been included in several authoritative national lists, receiving key support from projects such as the National 863 Program, the National Torch Program, the Ministry of Human Resources and Social Security's initiative to support overseas returnees starting businesses in China, key technological transformation projects in Shanghai, the Shanghai Pujiang Talent Program, and the Shanghai Municipal Science and Technology Commission's science and technology support projects in the biochemical field. Meanwhile, the company owns multiple invention patents and utility model patents related to cell technology, and is a member of the National Biological Sample Standardization Committee. As a high-tech enterprise dedicated to life science research, Angel Cell will unswervingly uphold the corporate spirit of "creating miracles and benefiting humanity," establish a cutting-edge cell biology platform, advance the development of cell therapy through practical actions, and strive to become a world-class cell enterprise, providing patients with stubborn diseases high-quality products and services, ensuring that everyone enjoys a healthy, happy, and high-quality life. For more information, please visit: *
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows